Laura began her journey at Pangea Bio as our first intern, and is now a permanent member of our team as a Senior Associate R&D and Operations. She supports efforts in assessing the merits of developing novel compounds for the treatment of high unmet need diseases, while also being an integral part of our commercial team.
Laura holds a MSc in Novel Therapies from Imperial College London (with Distinction), and a BSc in Biomedical Science from King’s College London (with First Class Honours). Throughout her studies, she has developed a growing interest in the power of bioactive entities found in nature, as well as the potential of psychedelics in helping patients around the world. She believes that such compounds could constitute the building blocks for the development of life-changing therapies.